Earnings Winners, Both Ways: Our Longs and Shorts Deliver Gains

http://wealthcreation.clubLeave a comment

📌 Update: Today’s earnings releases are delivering gains across both our long and short positions, highlighting the value of a selective, two-sided investment approach. Rather than relying solely on a rising market, the portfolio is benefiting from identifying both companies positioned to outperform and those where expectations leave room for disappointment. For high-net-worth investors, the significance extends beyond a single profitable session: it illustrates the potential to pursue returns from company-specific opportunities rather than market direction alone. Today’s results are encouraging, but sustained wealth creation requires more than getting an earnings call right—it demands disciplined position sizing, liquidity management and continued reassessment as prices adjust. The focus remains on converting research into returns while keeping risk proportionate to the opportunity

🔷 Featured allocation: US$80,000 | Four years  

At an assumed annual return of 12%, compounded annually, US$80,000 would grow to approximately US$125,881.55—a potential gain of US$45,881.55.

Explore Our Investment Plans

🔴 US$250,000+ | Five-year term  
Target: 0.5% monthly income plus 15% annually.

At an assumed annual return of 15% PLUS 0.5% per month compounded annually, US$250,000 would grow to approximately US$678,254.86—a potential gain of US$427,254.86

🟡 US$100,000+ | Two-year term  
Target: 0.5% monthly income plus 11% annually.

At an assumed annual return of 11% PLUS 0.5% per month compounded annually, US$100,000 would grow to approximately US$138,877.36—a potential gain of US$38,877.36

🟠 US$50,000 | Four-year term  
Proposed annual return: 9%.

At an assumed annual return of 9% US$50,000 would grow to approximately US$70,579.08—a potential gain of US$38,877.36

🔵 $1M | 2 years – Targeted: 0.5% monthly income plus 21% annually. 

At an assumed annual return of 21% PLUS 0.5% per month compounded annually, US$1M would grow to approximately US$1,516.706 —a potential gain of US$516,706

WhatsApp: bit.ly/Alpha-Binwani-Capital

Website: alphabinwanicapital.com

LinkedIn: bit.ly/Alpha-Binwani-Capital-LinkedIn

Newsletter: bit.ly/FreeAlphaNewsletter

#EarningsSeason #LongShortStrategy #WealthManagement #HighNetWorth #InvestmentStrategy #ActiveInvesting #PortfolioManagement #RiskManagement #CapitalPreservation #EquityResearch 

Merck Beats Estimates, Raises Profit Outlook Despite $400 Million Charge

http://wealthcreation.clubLeave a comment
‼️ 💊 BREAKING: Merck beat quarterly estimates and raised its adjusted EPS outlook to $2.77–$2.82 from $2.66–$2.76, including a $400 million, or 12-cent-per-share, charge tied to its SciBrunch licensing deal. The company is banking on Keytruda Qlex, a more convenient under-the-skin injection, to drive growth by transitioning patients from the original intravenous treatment.

Eli Lilly Smashes Estimates, Lifts Sales Outlook to $92 Billion on Weight-Loss Drug Demand

http://wealthcreation.clubLeave a comment
‼️ 💊 BREAKING: Eli Lilly beat estimates on resilient Zepbound and Mounjaro demand, reporting adjusted EPS of $7.48 versus $6.26 expected and revenue of $24.40 billion versus $22.61 billion forecast. It raised its 2026 revenue outlook to $91–$92 billion from $85–$87 billion, but lowered adjusted EPS guidance to $35–$36 from $35.50–$36.50, as $4.57 per share in deal-related charges more than offset a $4.07 increase in underlying profit guidance at the midpoint.